Tsolakidis, D.; Kyziridis, D.; Panoskaltsis, T.; Kalakonas, A.; Theodoulidis, V.; Chatzistamatiou, K.; Zouzoulas, D.; Tentes, A.-A.
Evaluating the Impact of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Interval and Secondary Debulking in Ovarian Cancer: A Systematic Review. Cancers 2025, 17, 904.
https://doi.org/10.3390/cancers17050904
AMA Style
Tsolakidis D, Kyziridis D, Panoskaltsis T, Kalakonas A, Theodoulidis V, Chatzistamatiou K, Zouzoulas D, Tentes A-A.
Evaluating the Impact of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Interval and Secondary Debulking in Ovarian Cancer: A Systematic Review. Cancers. 2025; 17(5):904.
https://doi.org/10.3390/cancers17050904
Chicago/Turabian Style
Tsolakidis, Dimitrios, Dimitrios Kyziridis, Theodoros Panoskaltsis, Apostolos Kalakonas, Vasileios Theodoulidis, Kimon Chatzistamatiou, Dimitrios Zouzoulas, and Antonios-Apostolos Tentes.
2025. "Evaluating the Impact of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Interval and Secondary Debulking in Ovarian Cancer: A Systematic Review" Cancers 17, no. 5: 904.
https://doi.org/10.3390/cancers17050904
APA Style
Tsolakidis, D., Kyziridis, D., Panoskaltsis, T., Kalakonas, A., Theodoulidis, V., Chatzistamatiou, K., Zouzoulas, D., & Tentes, A.-A.
(2025). Evaluating the Impact of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Interval and Secondary Debulking in Ovarian Cancer: A Systematic Review. Cancers, 17(5), 904.
https://doi.org/10.3390/cancers17050904
